Floatz logo

Car-20/19-T Cells

Diffuse Large B Cell Lymphoma

Medical College of WisconsinCell therapyPhase 1/2Active
CC
42/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
73/ 100

Competitive context

87 Active assets in the Diffuse Large B Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Beth Israel Deaconess Medical Center
Phase 4BBB
(+)-VINCRISTINE
Beth Israel Deaconess Medical Center
Phase 4BBB
Cytosin-Arabinosid
University of California, Davis
Phase 4BB
Ifosfamide
The First Affiliated Hospital with Nanjing Medical University
Phase 4BB
cc-5013
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 3BB

View all 50 →

Same molecule, other indications

Car-20/19-T Cells is also rated in:

non-Hodgkin lymphomaDormant
CC
Indicative ·
47 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
CC
Indicative ·
45 / 100
View asset →
Mantle Cell Lymphoma (MCL)Dormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →